Navigation Links
Smooth sailing: 'cruise ship virus' tackled by UH, Baylor College of Medicine

resence of Norwalk. If no light is reflected, then no protein/antibody bond has occurred and the patient does not have the Norwalk virus.

"This process may seem complicated, but it is actually much simpler than current tests for Norwalk," Ruchhoeft said. "By having the virus bridge the cube to the surface, you don't need to go through complex sample preparation steps, like extracting DNA, amplifying it and so forth. You could envision making a system work at a doctor's office or at an entry point to the cruise ship."

The ease with which Norwalk is spread makes it important to the field of biodefense, as well, which is a key point with the RCE helping to fund this research. According to Ruchhoeft, while the center is certainly interested in a more effective diagnostic tool for Norwalk, it foresees using this approach for other diseases, as well.

"If someone else has the antibody for other pathogens, then we can use it to coat the retroreflectors," Ruchhoeft said. "If we're successful in detecting the Norwalk virus, it opens up the possibility of creating a similar diagnostic tool for a variety of other infectious diseases."


'"/>

Source:University of Houston


Page: 1 2 3

Related biology news :

1. Clue found to Epstein-Barr virus ability to form and sustain tumors
2. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
3. Cancer cells suppress large regions of DNA by a reversible process that can be tackled
4. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
5. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
6. Williams College biologist explores photosynthetic apparatus
7. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
8. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
9. $6.5 Million Grant for Microarray Center at Yale School of Medicine
Post Your Comments:
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9